// App-Quantinova.ai

e12566 : Dendritic cells-based vaccine to inhibit triple-negative breast cancer cells proliferation.

Researchers

Presenter

  • Yong Huang

Principal Investigators

  • Meijun Long

  • Jun An

  • Mi Tang

  • Renbin Liu

Medical Centers

  • Department of Thyroid and Breast Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • Department of Thyroid and Breast Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • Department of General Surgery, Chongqing General Hospital, Chongqing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

Biomarkers

  • Cluster of Differentiation 11c

  • Cluster of differentiation 86

  • Human Leukocyte Antigen – DR isotype

  • Interleukin 12

Drug/Treatment

  • IL-12

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved